Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, has announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, after U.S. market close. The company will host a conference call and webcast on the same day at 5:00 p.m. Eastern Time to discuss its financial results and highlights.
Interested parties can access the live call via telephone by dialing toll-free 800-715-9871 for domestic callers. The live webcast can be accessed through the 'Events & Presentations' section of Oncocyte's website. A replay of the webcast will be available on the company's website shortly after the call concludes.
Oncocyte Corp. (Nasdaq: OCX), un'azienda di tecnologia diagnostica, ha annunciato che diffonderà i suoi risultati finanziari del secondo trimestre 2024 giovedì 8 agosto 2024, dopo la chiusura del mercato statunitense. L'azienda ospiterà una conference call e webcast lo stesso giorno alle 17:00 ora orientale per discutere i risultati finanziari e i punti salienti.
Le parti interessate possono accedere alla chiamata in diretta tramite telefono componendo il numero gratuito 800-715-9871 per i chiamanti nazionali. Il webcast dal vivo può essere accessibile attraverso la sezione 'Eventi & Presentazioni' del sito web di Oncocyte. Una registrazione del webcast sarà disponibile sul sito dell'azienda poco dopo la conclusione della chiamata.
Oncocyte Corp. (Nasdaq: OCX), una empresa de tecnología de diagnóstico, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el jueves 8 de agosto de 2024, después del cierre del mercado estadounidense. La empresa llevará a cabo una conferencia telefónica y webcast el mismo día a las 5:00 p.m. hora del Este para discutir sus resultados financieros y puntos destacados.
Las partes interesadas pueden acceder a la llamada en vivo por teléfono marcando el número gratuito 800-715-9871 para los llamantes nacionales. El webcast en vivo puede ser accesible a través de la sección 'Eventos y Presentaciones' del sitio web de Oncocyte. Una repetición del webcast estará disponible en el sitio de la compañía poco después de que concluya la llamada.
Oncocyte Corp. (Nasdaq: OCX)는 진단 기술 회사로, 2024년 2분기 재무 결과를 2024년 8월 8일 목요일 미국 시장 마감 후 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준 오후 5시에 전화 회의 및 웹캐스트를 진행하여 재무 결과 및 주요 내용을 논의할 예정입니다.
관심 있는 분들은 국내 전화로 무료 800-715-9871에 전화하여 실시간 통화에 접속할 수 있습니다. 실시간 웹캐스트는 Oncocyte 웹사이트의 '이벤트 및 발표' 섹션을 통해 접근할 수 있습니다. 회의 종료 후 곧바로 웹캐스트의 재방송이 회사 웹사이트에 게시될 예정입니다.
Oncocyte Corp. (Nasdaq: OCX), une entreprise de technologie diagnostique, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le jeudi 8 août 2024, après la fermeture du marché américain. L'entreprise tiendra une conférence téléphonique et un webinaire le même jour à 17h00, heure de l'Est, pour discuter de ses résultats financiers et des faits saillants.
Les parties intéressées peuvent accéder à l'appel en direct par téléphone en composant le numéro gratuit 800-715-9871 pour les appelants nationaux. Le webinaire en direct est accessible via la section 'Événements et présentations' du site web d'Oncocyte. Un enregistrement du webinaire sera disponible sur le site de l'entreprise peu après la fin de l'appel.
Oncocyte Corp. (Nasdaq: OCX), ein Unternehmen für diagnostische Technologien, hat angekündigt, dass die Finanzergebnisse für das zweite Quartal 2024 am Donnerstag, den 8. August 2024, nach Börsenschluss in den USA veröffentlicht werden. Am selben Tag wird das Unternehmen um 17:00 Uhr Eastern Time eine Telefonkonferenz und einen Webcast veranstalten, um seine Finanzergebnisse und Highlights zu besprechen.
Interessierte Parteien können über die Telefonnummer gebührenfreie 800-715-9871 für inländische Anrufer an dem Live-Anruf teilnehmen. Der Live-Webcast kann über den Bereich 'Veranstaltungen & Präsentationen' auf der Website von Oncocyte aufgerufen werden. Eine Wiederholung des Webcasts wird kurz nach dem Abschluss der Sitzung auf der Website des Unternehmens verfügbar sein.
- None.
- None.
Conference Call and Webcast on Thursday, August 8, 2024 at 2:00 p.m. PT / 5:00 p.m. ET
IRVINE, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced today that the company will release its second quarter 2024 financial results on Thursday, August 8, 2024, after U.S. market close. The company will host a conference call and webcast on Thursday, August 8, 2024, at 5:00 p.m. Eastern Time to discuss its financial results and highlights.
Interested parties may access the live call via telephone by dialing toll free 800-715-9871 for domestic callers. Once dialed in, ask to be joined to the Oncocyte Corporation call.
The live webcast of the call may be accessed by visiting the “Events & Presentations” section of the Company’s website at https://investors.oncocyte.com. A replay of the webcast will be available on the Company’s website shortly after the conclusion of the call.
CONFERENCE CALL DETAILS
Participant Toll-Free Dial-In Number: (800) 715-9871
Participant Toll Dial-In Number: +1 (646) 307-1963
Conference ID: 4153469
Webcast
https://events.q4inc.com/attendee/478523544
About Oncocyte
Oncocyte is a diagnostics technology company. The Company’s tests are designed to help provide clarity and confidence to physicians and their patients. VitaGraft™ is a clinical blood-based solid organ transplantation monitoring test. GraftAssure™ is a research use only (RUO) blood-based solid organ transplantation monitoring test. DetermaIO™ is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaCNI™ is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. For more information about Oncocyte, please visit https://oncocyte.com/. For more information about our products, please visit the following web pages:
VitaGraft Kidney™ - https://oncocyte.com/vitagraft-kidney/
VitaGraft Liver™ - https://oncocyte.com/vitagraft-liver/
GraftAssure™ - https://oncocyte.com/graftassure/
DetermaIO™ - https://oncocyte.com/determa-io/
DetermaCNI™ - https://oncocyte.com/determa-cni/
VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Oncocyte Corporation.
Contact:
Jeff Ramson
PCG Advisory
(646) 863-6893
jramson@pcgadvisory.com
FAQ
When will Oncocyte (OCX) release its Q2 2024 financial results?
What time is Oncocyte's (OCX) Q2 2024 earnings call scheduled for?
How can I access Oncocyte's (OCX) Q2 2024 earnings call?
What is the conference ID for Oncocyte's (OCX) Q2 2024 earnings call?
